secwatch.observer — SEC 8-K summary
======================================

Issuer:     Assertio Holdings, Inc. (ASRT)
CIK:        0001808665
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0001104659-25-098758
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Assertio, Hanmi amend ROLVEDON supply agreement; price cut mid-single digits
----------------------------------------------------------------------------

- Mid-single-digit price reduction on ROLVEDON drug substance from Hanmi, fixed through license term.
- Supplier may request price increases from 2028 if costs rise above threshold.
- Per-gram pricing decreases if global ROLVEDON volume exceeds unmet threshold.
- Spectrum must provide annual forecast; at least 50% of forecasted orders binding.
- No minimum purchase requirements; Spectrum may negotiate lower price if process cuts costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808665/000110465925098758/0001104659-25-098758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808665/000110465925098758/tm2528497d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-098758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer